<?xml version='1.0' encoding='utf-8'?>
<resource xmlns:xsi='http://www.w3.org/2001/XMLSchema-instance' xmlns='http://datacite.org/schema/kernel-3' xsi:schemaLocation='http://datacite.org/schema/kernel-3 http://schema.datacite.org/meta/kernel-3/metadata.xsd'>
<creators>
<creator>
<creatorName>Davidov, I.</creatorName>
<affiliation>Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu“, Moldova, Republica</affiliation>
</creator>
<creator>
<creatorName>Davidov, I.</creatorName>
<affiliation>Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu“, Moldova, Republica</affiliation>
</creator>
<creator>
<creatorName>Attia, G.</creatorName>
<affiliation>Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu“, Moldova, Republica</affiliation>
</creator>
<creator>
<creatorName>Arad, E.</creatorName>
<affiliation>Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu“, Moldova, Republica</affiliation>
</creator>
<creator>
<creatorName>Сидоренко, .</creatorName>
<affiliation>Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu“, Moldova, Republica</affiliation>
</creator>
</creators>
<titles>
<title xml:lang='en'>Biotechnological Tools in Genetics for Primary Prophylaxis of Essential Arterial Hypertension</title>
</titles>
<publisher>Instrumentul Bibliometric National</publisher>
<publicationYear>2023</publicationYear>
<relatedIdentifier relatedIdentifierType='ISBN' relationType='IsPartOf'></relatedIdentifier>
<subjects>
<subject>hypertension</subject>
<subject>gene mutation</subject>
<subject>polygenic</subject>
<subject>epigenetics</subject>
<subject>Biotechnology</subject>
</subjects>
<dates>
<date dateType='Issued'>2023</date>
</dates>
<resourceType resourceTypeGeneral='Text'>Conference Paper</resourceType>
<descriptions>
<description xml:lang='en' descriptionType='Abstract'><p>hypertension is one of the most spread cardiological diseases, due to recent biotechnological tools it is discovered that arterial hypertension is a polygenic disease. Another possible explanation might be the variety of the studied populations. The current results of genetic analyses of essential hypertension highlight the need for a more differentiated approach to the understanding of complex, polygenetic traits that implements gene-gene- and gene-environment interactions or differentiated functional testing of thoroughly phenotyped cohorts under standardised environmental conditions. The advancement of molecular genetics now permits the establishment of a connection between high blood pressure and certain traits. The aim of this work is to analyse how genetic testing for primary prophylaxis of arterial hypertension can be applied.</p></description>
</descriptions>
<formats>
<format>application/pdf</format>
</formats>
</resource>